Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution

DRUG2 trials

Sponsors

Allergan

Conditions

Glaucoma, Open-AngleOcular Hypertension

Phase 3

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01217606

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2011-01-31End: 2015-06-30Updated: 2016-12-20

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01241240

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2011-03-31End: 2013-09-30Updated: 2014-09-10

Related Papers

Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil<sup>☆</sup>.

2020-02-2010 citations

A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

Journal of Ophthalmology2017-01-0113 citations